Boston Total Cash From Operating Activities from 2010 to 2024

BSX Stock  USD 89.25  0.75  0.83%   
Boston Scientific Total Cash From Operating Activities yearly trend continues to be fairly stable with very little volatility. Total Cash From Operating Activities is likely to outpace its year average in 2024. During the period from 2010 to 2024, Boston Scientific Total Cash From Operating Activities regression line of annual values had r-squared of  0.57 and arithmetic mean of  1,321,850,000. View All Fundamentals
 
Total Cash From Operating Activities  
First Reported
1992-03-31
Previous Quarter
813 M
Current Value
B
Quarterly Volatility
259.7 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 B, Interest Expense of 193.9 M or Selling General Administrative of 5.2 B, as well as many indicators such as Price To Sales Ratio of 4.58, Dividend Yield of 3.0E-4 or PTB Ratio of 5.87. Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.
  
Check out the analysis of Boston Scientific Correlation against competitors.

Latest Boston Scientific's Total Cash From Operating Activities Growth Pattern

Below is the plot of the Total Cash From Operating Activities of Boston Scientific Corp over the last few years. It is Boston Scientific's Total Cash From Operating Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Boston Scientific's overall financial position and show how it may be relating to other accounts over time.
Total Cash From Operating Activities10 Years Trend
Slightly volatile
   Total Cash From Operating Activities   
       Timeline  

Boston Total Cash From Operating Activities Regression Statistics

Arithmetic Mean1,321,850,000
Geometric Mean975,722,015
Coefficient Of Variation54.45
Mean Deviation539,226,667
Median1,269,000,000
Standard Deviation719,791,202
Sample Variance518099.4T
Range2.6B
R-Value0.76
Mean Square Error237208.6T
R-Squared0.57
Significance0
Slope122,031,607
Total Sum of Squares7253391.2T

Boston Total Cash From Operating Activities History

20242.6 B
20232.5 B
20221.5 B
20211.9 B
20201.5 B
20191.8 B
2018310 M

About Boston Scientific Financial Statements

Boston Scientific investors use historical fundamental indicators, such as Boston Scientific's Total Cash From Operating Activities, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Boston Scientific. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Cash From Operating Activities2.5 B2.6 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.